aspirin has been researched along with T-Cell Lymphoma in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study explores the potential of the anti-neoplastic action of aspirin in a transplantable murine tumour model of a spontaneously originated T-cell lymphoma designated as Dalton's lymphoma." | 7.78 | Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival. ( Bharti, AC; Kumar, A; Singh, SM; Tyagi, A; Vishvakarma, NK, 2012) |
| "Aspirin is an anti-inflammatory drug demonstrated to possess a tremendous anticancer potential." | 5.38 | Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host. ( Bharti, AC; Kumar, A; Singh, SM; Vishvakarma, NK, 2012) |
| "The present study explores the potential of the anti-neoplastic action of aspirin in a transplantable murine tumour model of a spontaneously originated T-cell lymphoma designated as Dalton's lymphoma." | 3.78 | Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival. ( Bharti, AC; Kumar, A; Singh, SM; Tyagi, A; Vishvakarma, NK, 2012) |
| "Aspirin is an anti-inflammatory drug demonstrated to possess a tremendous anticancer potential." | 1.38 | Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host. ( Bharti, AC; Kumar, A; Singh, SM; Vishvakarma, NK, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A | 3 |
| Vishvakarma, NK | 2 |
| Tyagi, A | 1 |
| Bharti, AC | 3 |
| Singh, SM | 3 |
3 other studies available for aspirin and T-Cell Lymphoma
| Article | Year |
|---|---|
Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival.
Topics: Administration, Oral; Animals; Apoptosis; Aspirin; Cell Cycle; Cell Death; Cell Survival; Cyclin B1; | 2012 |
Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host.
Topics: Androgens; Animals; Antineoplastic Agents; Aspirin; Cell Cycle; Cell Proliferation; Cell Survival; D | 2012 |
Effect of aspirin administration on reversal of tumor-induced suppression of myelopoiesis in T-cell lymphoma bearing host.
Topics: Animals; Apoptosis; Aspirin; Bone Marrow Cells; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; | 2012 |